miR-139-5p is a regulator of metastatic pathways in breast cancer. - Wikidata - awgldk - TriplyDB

miR-139-5p is a regulator of metastatic pathways in breast cancer.

miR-139-5p is a regulator of metastatic pathways in breast cancer.

http://www.wikidata.org/entity/Q37448717

about

Bioinformatic Interrogation of 5p-arm and 3p-arm Specific miRNA Expression Using TCGA Datasets Integration of mRNA expression profile, copy number alterations, and microRNA expression levels in breast cancer to improve grade definition.Role of differentially expressed microRNA-139-5p in the regulation of phenotypic internal anal sphincter smooth muscle tone.microRNA-139-5p exerts tumor suppressor function by targeting NOTCH1 in colorectal cancer MiR-139-5p inhibits migration and invasion of colorectal cancer by downregulating AMFR and NOTCH1.MicroRNA-139-3p indicates a poor prognosis of colon cancer.miRNA - Therapeutic tool in breast cancer? Where are we now?Transcriptional dynamics reveal critical roles for non-coding RNAs in the immediate-early response.Re-thinking miRNA-mRNA interactions: intertwining issues confound target discovery.Detection of miRNA regulatory effect on triple negative breast cancer transcriptome.MicroRNA-139-5p inhibits cell proliferation and invasion by targeting insulin-like growth factor 1 receptor in human non-small cell lung cancer.MicroRNA screening identifies circulating microRNAs as potential biomarkers for osteosarcoma.Trichostatin A induces a unique set of microRNAs including miR-129-5p that blocks cyclin-dependent kinase 6 expression and proliferation in H9c2 cardiac myocytes.High-throughput sequencing reveals differential expression of miRNAs in prehierarchal follicles of laying and brooding geese.Integrated microRNA and mRNA responses to acute human left ventricular ischemia.Histone methylation-mediated silencing of miR-139 enhances invasion of non-small-cell lung cancer.The LPA1/ZEB1/miR-21-activation pathway regulates metastasis in basal breast cancer.Hsa-miR-139-5p inhibits proliferation and causes apoptosis associated with down-regulation of c-Met miR-15b and miR-21 as Circulating Biomarkers for Diagnosis of Glioma Predicting MicroRNA Biomarkers for Cancer Using Phylogenetic Tree and Microarray Analysis.miR-139-5p Inhibits the Epithelial-Mesenchymal Transition and Enhances the Chemotherapeutic Sensitivity of Colorectal Cancer Cells by Downregulating BCL2 Molecular Analysis of Neutrophil Differentiation from Human Induced Pluripotent Stem Cells Delineates the Kinetics of Key Regulators of Hematopoiesis.miR-139-5p regulates proliferation, apoptosis, and cell cycle of uterine leiomyoma cells by targeting TPD52.Analysis of clock gene-miRNA correlation networks reveals candidate drivers in colorectal cancer.MiR-139-5p as a novel serum biomarker for recurrence and metastasis in colorectal cancer.MiR-139-5p reverses CD44+/CD133+-associated multidrug resistance by downregulating NOTCH1 in colorectal carcinoma cells.MiR-139-5p: promising biomarker for cancer.Potential role of miR-139-5p in cancer diagnosis, prognosis and therapy MicroRNA-139-5p inhibits bladder cancer proliferation and self-renewal by targeting the Bmi1 oncogene.An update on sputum MicroRNAs in lung cancer diagnosis.Role of HCP5-miR-139-RUNX1 Feedback Loop in Regulating Malignant Behavior of Glioma Cells miR-139-5p controls translation in myeloid leukemia through EIF4G2.miR-139-5p suppresses cancer cell migration and invasion through targeting ZEB1 and ZEB2 in GBM.MicroRNA-139-5p regulates C2C12 cell myogenesis through blocking Wnt/β-catenin signaling pathway.The microRNA signatures: aberrantly expressed microRNAs in head and neck squamous cell carcinoma.A network-biology perspective of microRNA function and dysfunction in cancer.Hyperthermia-driven aberrations of secreted microRNAs in breast cancer in vitro.Crucial microRNAs and genes of human primary breast cancer explored by microRNA-mRNA integrated analysis.Functional proteomics outlines the complexity of breast cancer molecular subtypes.MicroRNA expression profiles and target prediction in neonatal Wistar rat lungs during the development of bronchopulmonary dysplasia

P2860

Q30488342-82CAEAC6-0C95-46C0-83B5-1F59801BC416 Q33670486-9ED402B0-64BF-4A4D-A964-115585BFDBE1 Q33684545-D334064E-EBAE-4457-9B6C-08CF75B9B206 Q33784290-87D81D9F-AE23-4569-9B98-03B55E6470C8 Q34477508-093D7D03-7F3A-4BAB-A657-320CF78940E7 Q34733024-BF35FC32-EF79-4FA9-87AC-DDFAAEAE17C7 Q35113386-19D07971-1E15-47B1-B45A-2AD949BA7294 Q35462820-F7F05A19-A8B4-4506-BC6F-38AEA54812AE Q35561618-4CC4B755-7A4A-4D3B-A623-961D52CB0A27 Q35653875-C76BBCB4-9989-46DD-AE63-FB40D273346B Q35741052-ACFF134E-78C6-471A-A069-19926C5C41B5 Q35943345-49FEF17E-601E-4BC7-98A3-3CDDB6851D26 Q35946789-F068ADDB-0DEF-4A54-B114-4DD571DEB04C Q36023301-51909C66-2DCC-48A3-8131-3143E93E8239 Q36122833-14F5F008-19A6-469F-86E9-FEA91F598862 Q36201501-68A0AE9A-8B95-44D0-B8A6-5EAA14F4011A Q36299766-1059665D-63B0-42F0-9696-84DEE52DD164 Q36545471-45991594-05C5-4BF9-BC79-9ED806F13177 Q36608190-4D8D1654-E9D6-4961-BAB4-E02737FE7568 Q36939358-274EDCE8-28FE-4C08-87B2-7BB1D85114B6 Q36950630-2024028C-A857-4DB2-8D85-5D03120412C4 Q36968311-23999CC9-4C58-4585-9CD6-DB0F55FB3B11 Q37344530-39E4D7AA-9443-4F91-9DDA-FE1BC3875C03 Q37564446-6BFB72EC-09FE-4E9A-95E1-3DB73602CC70 Q37682257-20A758F3-533D-46BD-B7EB-D4DD50467951 Q37688905-9F441B2A-C3D8-47D0-98FD-DDC66B464AAC Q38359431-AB8886F0-EDEA-44B0-9DCD-2010FA271182 Q38645381-E432A222-6E1D-4E89-A010-B335C4E93165 Q38696912-228CD10B-B467-422F-8A3D-9F9031C3F024 Q38729060-F4EACC35-68CD-4CAF-B0CA-390050C1FAAA Q38756966-F73F79C3-2A5F-4733-B136-07017C31426D Q38854034-B73C4495-3A04-4759-BB67-7ECA21A53FDF Q38891966-A3BAA40A-CB66-4DFB-9823-48067A6EFC30 Q38926588-0943D737-93D8-41EB-A889-23E0388D156D Q38936321-0ECE92A7-FCD0-4EC9-A457-EC5D71E40A21 Q38994476-084C9614-539E-4221-896C-3AFB2A58E99C Q39630301-D8B5F2E8-6B63-458C-B118-76C2CEBD20B8 Q41438471-8EACFDD3-F18E-4501-BF3A-222F8DB080FB Q41564586-D1AE3BD6-2895-4C36-A7A1-5B657BB3FD88 Q41860642-D635DAFC-9233-42A6-8932-7AE61F19E5A3

P2860

miR-139-5p is a regulator of metastatic pathways in breast cancer.

http://www.wikidata.org/entity/Q37448717

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 24 October 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

miR-139-5p is a regulator of metastatic pathways in breast cancer.

@en

miR-139-5p is a regulator of metastatic pathways in breast cancer.

@nl

type

label

miR-139-5p is a regulator of metastatic pathways in breast cancer.

@en

miR-139-5p is a regulator of metastatic pathways in breast cancer.

@nl

prefLabel

miR-139-5p is a regulator of metastatic pathways in breast cancer.

@en

miR-139-5p is a regulator of metastatic pathways in breast cancer.

@nl

P1433

Q37448717-7ADC180B-1830-4EF7-AC8B-52ED1050EB0B

P1476

Q37448717-93BB7F93-9ECD-4AF4-9631-B4CBF5FDC578

P2093

Q37448717-000B8CE9-32E2-4586-A040-3BBE0B23E63B

Q37448717-03EFA329-E22E-4761-B822-502512F409C9

Q37448717-34E3447E-A637-490C-B8D3-32EDA2AAE4E1

Q37448717-3AC1B0D9-8B27-4866-8EA2-C7D46FB48D47

Q37448717-41B4E880-1E11-4306-9904-7375E3A0D6D4

Q37448717-8061240F-1B9E-48BC-8C6E-13E18BD936D8

Q37448717-896AA180-8DCA-4FD9-B4C8-86381C25B476

Q37448717-F8B6462D-81E4-42F5-BEB7-33C149CB12F3

P2860

Q37448717-00801A87-CD3B-44D3-B49B-96ED36042F8B

Q37448717-17773BA8-AD47-4B6C-ADD9-68CDF6455326

Q37448717-17E4473E-5043-4206-AEEB-215C84449B18

Q37448717-1B94975D-6766-4EC0-8E49-76E2F91ACC67

Q37448717-1ED99ED2-C1CC-4ABD-BE44-1B2FD9F003E1

Q37448717-2CA8EB4C-2A59-4B9C-8A7E-E3225ADDE87B

Q37448717-2ECA2C27-FA16-4C10-950C-DB4D77812F4E

Q37448717-3CA31112-AE87-4B6F-848D-92FF47ABB43C

Q37448717-3E78F5D8-F44D-4D8C-A16F-5CCABD85D9D2

Q37448717-3EEA7105-CEB1-4604-B98E-6C89D5D2E45A

P304

Q37448717-3107C230-4A99-4746-94C1-EC1413E48ACC

P31

Q37448717-DEF8A11E-7551-4C27-B095-11183B6F05D4

P356

Q37448717-1B028A88-D841-47AE-AC5A-F1D26AED2DBC

P407

Q37448717-B43BD1AB-0518-4A17-971C-7700354CE899

P433

Q37448717-796C97AD-25A3-4303-8AAE-383379DD2C85

P478

Q37448717-EF72F169-7DFB-42AA-938C-EA12C812E137

P50

Q37448717-336E33C9-4F44-49E0-8CC9-EA19D9332912

Q37448717-728B3B96-0C26-455C-8D89-99E9F79F3484

Q37448717-898FCB3F-199E-498A-81B4-9DBCDD117BCE

Q37448717-A34B8CCF-2106-40F4-82ED-7CC7B1CFEC52

P577

Q37448717-5D28AC3F-C5E2-4020-AF41-DE7F03787A13

P5875

Q37448717-8660DB5F-0F87-4643-A74F-BD9A3E59E832

P698

Q37448717-03592AEE-76C6-410A-9CFE-86E65BD2EF4E

P932

Q37448717-8D5BD8E9-39DE-4320-8CFE-98B210130186

P356

P1433

P1476

miR-139-5p is a regulator of metastatic pathways in breast cancer.

@en

P2093

Alexander Vlassov

http://www.w3.org/2001/XMLSchema#string

Anita L Steptoe

http://www.w3.org/2001/XMLSchema#string

Hilary C Martin

http://www.w3.org/2001/XMLSchema#string

Katia Nones

http://www.w3.org/2001/XMLSchema#string

Keerthana Krishnan

http://www.w3.org/2001/XMLSchema#string

Mythily Mariasegaram

http://www.w3.org/2001/XMLSchema#string

Nic Waddell

http://www.w3.org/2001/XMLSchema#string

Nicole Cloonan

http://www.w3.org/2001/XMLSchema#string

P2860

Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation

Breast cancer metastasis suppressor 1 (BRMS1) is destabilized by the Cul3-SPOP E3 ubiquitin ligase complex

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2

MicroRNA-182-5p targets a network of genes involved in DNA repair

The miR-17-5p microRNA is a key regulator of the G1/S phase cell cycle transition

A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis

A new non-linear normalization method for reducing variability in DNA microarray experiments.

Wnt/β-catenin signaling and disease

MicroRNAs and their isomiRs function cooperatively to target common biological pathways

P304

1767-1780

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1261/RNA.042143.113

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P50

Sean M. Grimmond

Peter T. Simpson

Sunil R Lakhani

Diwakar R Pattabiraman

P577

2013-10-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258044362

http://www.w3.org/2001/XMLSchema#string

P698

24158791

http://www.w3.org/2001/XMLSchema#string

P932

3884652

http://www.w3.org/2001/XMLSchema#string